Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Libevitug, an antibody targeting Hepatitis B Virus Surface Antigen.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Invikafusp, an antibody targeting TRBV6&TRBV10.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Indenebart, an antibody targeting alpha-synuclein.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gruticibart, an antibody targeting Factor XI.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gimistotug, an antibody targeting OX40.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Eltrekibart, an antibody targeting CXCL1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ebribafusp, an antibody targeting C3d.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Crebankitug, an antibody targeting IL-7R.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Coramitug, an antibody targeting Misfolded TTR.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Cepeprubart, an antibody targeting SELPLG.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Cafelkibart, an antibody targeting CCR8.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Adakitug, an antibody targeting CXCL8.